about
Somatic Mutation Analyses in Studies of the Clonal Evolution and Diagnostic Targets of Prostate Cancer.Ischemia in pelvic organs as an independent pathogenic factor in the development of benign prostatic hyperplasia and urinary bladder dysfunction.Detection of Rare Mutations by Routine Analysis of KRAS, NRAS, and BRAF Oncogenes.[A new WHO classification of prostate tumors].[PCA3 AND TMPRSS2:ERG GENES EXPRESSION IN BIOPSIES OF BENIGN PROSTATE HYPERPLASIA, INTRAEPITHELIAL NEOPLASIA, AND PROSTATE CANCER].[Hormone Resistance and Neuroendocrine Differentiation Due to Accumulation of Genetic Lesions during Clonal Evolution of Prostate Cancer].[Markers for non-invasive molecular genetic diagnosis of oncourological diseases]
P50
Q38703676-92822D7D-91A9-4BF4-9140-DFDDBEABCFA3Q41036248-8D1D24F1-8631-4AF6-AA3B-7B7BECC370DAQ48009778-5E55C807-704B-4459-AE6E-545A09962FF1Q53033287-C61A6C10-1EF6-4DE6-9350-054F17A8A758Q53182402-3AA37028-4565-44FC-97AC-E05E8004C497Q53791847-03599F5B-D8B3-461A-B5B9-B289D0B9AA42Q95615517-5B96D69C-7E27-41A4-908A-632122993DDB
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
G D Efremov
@en
G D Efremov
@nl
type
label
G D Efremov
@en
G D Efremov
@nl
prefLabel
G D Efremov
@en
G D Efremov
@nl
P31
P496
0000-0002-8822-8119